All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
FLACU / Frazier Lifesciences Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
|
|
|
|
|
|
|
|
APTX / Aptinyx Inc.
|
|
|
|
|
|
|
|
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
STRO / Sutro Biopharma, Inc.
|
|
|
|
|
|
|
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
GRTS / Gritstone bio, Inc.
|
|
|
|
|
|
|
|
IMGO / Imago BioSciences Inc
|
|
|
|
|
|
|
|
NABRIVA THERAPEUTICS PLC
/ SHS (G63637113) |
|
|
|
|
|
|
|
PARDES BIOSCIENCES INC
/ (69945Q105) |
|
|
|
|
|
|
|
MRUS / Merus N.V.
|
|
|
|
|
|
|
|
ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
PASG / Passage Bio, Inc.
|
|
|
|
|
|
|
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TCDA / Tricida Inc
|
|
|
|
|
|
|
|
PHAT / Phathom Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KRYS / Krystal Biotech, Inc.
|
|
|
|
|
|
|
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
ALNA / Allena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
TYRA / Tyra Biosciences, Inc.
|
|
|
|
|
|
|
|
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
PCVX / Vaxcyte, Inc.
|
|
|
|
|
|
|
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KDNY / Chinook Therapeutics Inc
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|